Lorbrexen 100mg Tablet (Lorlatinib)
Prescription RequiredManufactured By
Everest
Pack Of
30
Salt Composition
Lorlatinib
Storage
Keep in cold place
Fast Delivery
Easy Returns
Secure Payments
Up to 60% Discounts
ALL SUBSTITUTES
Lorbrena 100mg Tablet
Overview
Lorbrexen 100mg Tablet is a prescription-based anticancer medicine used in the treatment of metastatic non-small cell lung cancer. The active ingredient of the Lorbrexen is Lorlatinib which belongs to the drug class of tyrosine kinase inhibitors.
It works by blocking the function of abnormal protein that promote the growth of cancer cells. Lorlatinib Tablet is usually given in combination with another anticancer medicine as a part of combination therapy to increase the efficacy of the treatment.
Indication
Head and neck cancer, kidney cancer, lung cancer, liver cancer, skin cancer
Side Effects
The human body shows undesired symptoms after taking Lorlatinib 100mg Tablet (Lorbrexen). Usually, they disappear with time as the body adjusts to the medicine. These side effects don't need special medical attention. It is advised to consult your doctor if these symptoms become unmanageable.
Common Side Effects
- Some of the common side effects of Lorbrexen Tablet are mentioned below:
- ● Rash
- ● Cough
- ● Fatigue
- ● Diarrhea
- ● Confusion
- ● Headache
- ● Chest pain
- ● Constipation
- ● Memory loss
- ● Breathlessness
- ● Abdominal pain
- ● Nausea & vomiting
- ● Difficulty in speaking
- ● Swelling in feet and hand
- ● Yellowing of skin and eyes
- ● Increase in cholesterol levels
How To Use
Lorbrexen 100mg Tablet (Lorlatinib) is a prescription-based anticancer drug that should be administered orally. It is advised to take this capsule after consulting your healthcare expert.
This tablet should be swallowed as a whole with water. Don't crush, chew, or break it. It can be taken with or without food. Never skip a dose or double dose.
Reference
● Shaw, Alice T., Todd M. Bauer, Filippo de Marinis, Enriqueta Felip, Yasushi Goto, Geoffrey Liu, Julien Mazieres et al. "First-line lorlatinib or crizotinib in advanced ALK-positive lung cancer." New England Journal of Medicine 383, no. 21 (2020): 2018-2029.
● Solomon, B. J., Besse, B., Bauer, T. M., Felip, E., Soo, R. A., Camidge, D. R., ... & Shaw, A. T. (2018). Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study. The Lancet Oncology, 19(12), 1654-1667.
● Syed, Y. Y. (2019). Lorlatinib: First Global Approval. Drugs, 79(1), 93.
● Solomon, B. J., Besse, B., Bauer, T. M., Felip, E., Soo, R. A., Camidge, D. R., ... & Shaw, A. T. (2018). Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study. The Lancet Oncology, 19(12), 1654-1667.
● Shaw, A. T., Bauer, T. M., de Marinis, F., Felip, E., Goto, Y., Liu, G., ... & Solomon, B. J. (2020). First-line lorlatinib or crizotinib in advanced ALK-positive lung cancer. New England Journal of Medicine, 383(21), 2018-2029.
Safety Advice
- • Alcohol: The interaction of alcohol with this drug is still unknown. It is advisable not to consume alcohol while taking Lorlatinib 100mg Tablet (Lorbrexen). It is advised to consult your doctor for further information.
- • Pregnancy: Lorbrexen 100mg Tablet (Lorlatinib) may be considered unsafe during pregnancy. Please consult your doctor in such condition.
- • Breastfeeding: Lorlatinib 100mg Tablet (Lorbrexen) is probably not safe if you're breastfeeding. Kindly consult your doctor.
- • Driving: It is advisable not to drive or operate heavy machinery as you may feel dizzy after taking Lorbrexen 100mg Tablet (Lorlatinib).
- • Kidney: Share your medical history with your healthcare expert in case of kidney disease before taking Lorbrexen 100mg Tablet (Lorlatinib).
- • Liver: Inform your doctor before starting Lorlatinib 100mg Tablet (Lorbrexen) if you have liver disease to avoid any serious side effects.
FAQs
Why do doctors prescribe Lorbrexen 100mg Tablet (Lorlatinib)?
This medicine is given to adults diagnosed with Non-small cell lung cancer (NSCLC).
What is the right way of taking the Lorbrexen 100mg Tablet (Lorlatinib)?
Lorbrexen Tablet is taken orally with or without food as per the doctor's advice. It is consumed at the same time each day for better results. It is recommended not to crush, chew, or split the capsules; take them as a whole.
What are the commonly observed side effects of Lorbrexen 100mg Tablet (Lorlatinib)?
The most common side effects of this medicine include Diarrhea, Headache, Tiredness, Mouth sores, Muscle or joint pain, Stomach pain, and difficulty breathing. It is advised to go for regular liver function tests to examine the liver function.
Who should avoid taking Lorbrexen 100mg Tablet (Lorlatinib)?
People diagnosed with severe liver and kidney disorders are advised to consult their healthcare professionals before taking this medicine.
Can the Lorlatinib 100mg Tablet (Lorbrexen) be given in combination therapy with other medications?
No, there are chances that Lorlatinib may interact with certain drugs. It is crucial to inform your healthcare expert if you are already taking any medication.
Marketer Details
Everest
Author Details
Written By:
Nonish Sharma
I am a medical content writer with a strong academic background in life sciences, holding an M.Sc. in Biotechnology... Read More
Reviewed By:
Vaibhav Shakya
Dr. Vaibhav Shakya, MD, is a Medical reviewer and medicine expert at Globans Pharma, with more than 9 years of experienc... Read More
Want to know More
Check our Editor Policy
Disclaimer
Globanspharma main goal is to ensure that its consumers get correct, authentic, and reliable information that has been examined by medical professionals. This website's content has only been created for informational purposes. However, this is not meant to replace the medical advice and treatment given by a qualified physician. The information presented herein may not cover everything about particular lab tests, medicines, and health conditions, all possible side effects, and warnings. Please discuss all your queries related to any medication and illness with your doctor. We intend to support and maintain the doctor-patient relationship, not to substitute it or take its place.
